Literature DB >> 2496711

Immunoglobulin G subclass deficiency and susceptibility to pyogenic infections in patients with AIDS-related complex and AIDS.

J M Parkin1, M Helbert, C L Hughes, A J Pinching.   

Abstract

Total immunoglobulin (Ig) and IgG subclass levels were measured in 72 patients with AIDS or AIDS-related complex (ARC). IgG2 subclass levels were found to be significantly decreased in the AIDS/ARC patients with pyogenic infections compared with both similar individuals without bacterial disease and the HIV-negative control group.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2496711

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  13 in total

Review 1.  Therapeutic strategies in common variable immunodeficiency.

Authors:  W A Carrock Sewell; Matthew Buckland; Stephen R A Jolles
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 3.  Antibody responses in HIV infection.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

Review 4.  AIDS and the lung. 7. Treatment of lung disease in patients with the acquired immune deficiency syndrome.

Authors:  D M Mitchell; M A Johnson
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

5.  Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults.

Authors:  N F Crum-Cianflone; G Collins; G Defang; E Iverson; L E Eberly; C Duplessis; J Maguire; A Ganesan; B K Agan; T Lalani; T Whitman; C Brandt; D Faix; P J Blair; T Burgess
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 6.  Intravenous immunoglobulin for secondary immunodeficiency.

Authors:  P L Yap
Journal:  Blut       Date:  1990-01

Review 7.  Should patients positive for HIV infection receive pneumococcal vaccine?

Authors:  A Jain; S Jain; V Gant
Journal:  BMJ       Date:  1995-04-22

8.  Clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drugs: comparison with homosexual seroconverters and infected and non-infected intravenous drug misusers.

Authors:  G H Mientjes; E J van Ameijden; H M Weigel; J A van den Hoek; R A Coutinho
Journal:  BMJ       Date:  1993-02-06

9.  Immunoglobulin G subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non-infected patients with tuberculosis.

Authors:  C T Da Costa; S Khanolkar-Young; A M Elliott; K M Wasunna; K P McAdam
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

10.  Risk factors in HIV-1-infected patients developing repetitive bacterial infections: toxicological, clinical, specific antibody class responses, opsonophagocytosis and Fc(gamma) RIIa polymorphism characteristics.

Authors:  A Payeras; P Martinez; J Milà; M Riera; A Pareja; J Casal; N Matamoros
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.